Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInternational Spine Study Group Foundation

About this trial

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

>18 years of age at the time of treatment

EOS full body or standing 36" AP & Lateral images of entire spine

Posterior spine fusion with pedicle screw fixation construct of 5 or more levels

Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system

Disqualifiers

Active spine tumor or infection

Deformity due to acute trauma

Prisoners

Women who are pregnant

Trial population

Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Index or revision spine surgery for complex adult spinal deformity

    Procedure/Surgery

    Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.

Treatment groups

225 Participants
are divided into 1 treatment group
Group A: VersaTie1 intervention

Trial outcomes

Primary outcomes

1

Scoliosis Research Society (SRS) 22r

Scoliosis specific patient reported outcome

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
2

Oswestry

Spine specific patient reported outcome

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
3

Veterans RAND 12 Item Health Survey (VR-12)

Patient reported outcome

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
4

Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety

Patient reported outcome

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

Secondary outcomes

1

Edmonton Frail Scale

Evaluate frailty on scale of 0 to 17 where higher scores mean more frail

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
2

Canadian Study of Health and Aging (CSHA)

Frailty scale of 1 to 9; higher scores mean more frail

Time frame
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
3

Adverse Events

Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study \[Time Frame: 3 months and 1, 2, 5 \& 10 year post treatment\]

Time frame
3 months and 1, 2, 5 & 10 year post treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.